Improvement of quantitative testing of liver function in patients with chronic hepatitis C after installment of antiviral therapy

Figure 1 Quantitative testing of liver function in patients with hepatitis C. Shown are mean±SD of QTLF values in healthy controls (n = 25) and HCV patients (n = 50) before and 3 mo after antiviral therapy, divided into responders (n = 36) and non-responders (n = 14). aP<0.05 vs healthy controls; cP<0.05 vs pre-treatment values. A: Aminopyrine breath test. ABT (% dose-kg/mmol CO2); B: Galactose elimination capacity. GEC (mg/min-kg); C: Sorbitol clearance. SCl (mL/min-kg); D: Indocyanine green clearance. ICG (L/min).